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Aspergillus-Associated Cerebral Aneurysm Successfully Treated 
by Endovascular and Surgical Intervention with Voriconazole in 
Lupus Nephritis Patient
During the last five decades, long-term therapy with immunosuppressive agents such as 
pulse cyclophosphamide in conjunction with high-dose corticosteroids has enhanced both 
patient survival and renal survival in patients with diffuse proliferative lupus nephritis. 
Nevertheless, severe side effects such as infectious complications remain the main cause of 
morbidity and mortality. Central nervous system aspergillosis is uncommon but life-
threatening in lupus patients. In this single-patient case study, carotid aneurysm with 
sphenoidal sinusitis was suspected when severe epistaxis occurred during 
cyclophosphamide pulse therapy. With anti-fungal therapy, a graft stent was successfully 
deployed to the aneurysm and specimens of sphenoidal mucosa showed typical hyphae, 
indicating aspergillosis. Three months after stopping voriconazole treatment, two cerebral 
aneurysms that were revealed on MR images were successfully removed by aneurysmal 
clipping. The patient remained alive at one-year follow-up with lupus nephritis in 
remission. The rarity and high mortality of aspergillus-related fungal aneurysms have led to 
most cases being recognized postmortem. However, such aneurysms must be diagnosed 
early to prevent fatal complications by performing appropriate management such as 
surgical procedure or endovascular intervention.
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CASE REPORT
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INTRODUCTION
During the last five decades, long-term therapy with immuno-
suppressive agents such as pulse cyclophosphamide in conjunc-
tion with high-dose corticosteroids has enhanced both patient 
survival and renal survival in patients with diffuse proliferative 
lupus nephritis (DPLN) (1-4). However, the beneficial effect of 
cyclophosphamide must be weighed against its considerable 
side effects, such as severe infectious complications. Infections 
are an important cause of treatment-related morbidity and mor-
tality in systemic lupus erythematosus (SLE). It is estimated that 
at least 50% of them will suffer a severe infectious episode dur-
ing the course of the disease (5). A broad spectrum of infections 
have been reported in SLE, including bacterial, mycobacterial, 
viral, fungal and parasitic infections (6). Although fungal infec-
tions account for a significant number of infections (6-8), asper-
gillosis, especially invasive aspergillosis, has seldom been de-
scribed (9). Moreover, central nervous system (CNS) aspergillo-
sis is extremely rare and no case of aspergillus cerebral aneurysm 
has been reported.
  We describe here the first case of internal carotid artery (ICA) 
mycotic aneurysm due to aspergillosis in an immunocompro-
mised DPLN patient who was successfully treated with combi-
nation of antifungal therapy, graft stent insertion and aneurys-
mal neck clipping. 
CASE DESCRIPTION
A 46-yr-old woman was referred to our hospital for generalized 
edema. Her edema had started one week previously after a one-
week history of mild febrile sense, headache and cough. The lab-
oratory test on admission showed anemia (hemoglobin 9.1 g/
dL, hematocrit 26.8%), thrombocytopenia 98 × 10
3/μL) with 
acute renal failure (blood urea nitrogen 31 mg/dL, creatinine 
1.5 mg/dL) and her urinalysis showed moderate hematuria and 
proteinuria (4.6 g/day). Her serologic tests were abnormal with 
high ANA titer of 1:160, low C3 of 35 mg/dL (normal 70-150 mg/ 
dL) and C4 of 6 mg/dL (normal 10-35 mg/dL), and elevated anti-
dsDNA autoantibody titer of 146 IU/mL (normal  < 10 IU/mL). 
She had a kidney biopsy and was diagnosed with DPLN (ISN/Kim YC, et al.  •  Successfully Treated Fungal Infection in Lupus Nephritis
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RPS Class IV-G(A)).
  In the absence of any evidence of infection, she received two 
courses of steroid pulse therapy (1 g of methylprednisolone) 
followed by oral high dose steroid (1 mg/kg of prednisolone). 
Before receiving the third course of steroid pulse therapy, her 
chest radiograph showed a 4 cm-sized round opacity in her right 
upper lung field, although she had no respiratory symptoms. 
Computed tomography (CT) scan of the chest disclosed a mass 
with central necrosis surrounded by a halo of ground-glass at-
tenuation. These images were highly suggestive of invasive pul-
monary aspergillosis. Therefore, she underwent a percutane-
ous needle biopsy for the lesion, but no microorganisms were 
revealed by histological examinations including Grocott’s me-
thenamine silver staining, acid-fast staining, periodic acid-Schiff 
(Ed- the acronyms GMS and PAS are unnecessary as they are 
not used anywhere else in the paper) staining and Gram stain-
ing of the lung tissue specimen. 
  By clinical impression, the patient commenced a course of 
amphotericin B due to the possibility of other fungal infections, 
such as mucormycosis. After one month, the lesion was cleared 
up in the chest CT, amphotericin B was stopped, and chest radio-
graph did not show any lung lesion suggestive of active infec-
tion such as fungal infection. Subsequently, she received nine 
courses of cyclophosphamide pulse therapy (monthly 6 times 
and quarterly 3 times with total dose of 5.75 g) over 15 months. 
Oral steroid was tapered down from daily 5 mg/kg to daily 5 mg. 
At this time, her urinalysis showed no hematuria and protein-
uria was around 100 mg/day with normal kidney function (0.9 
mg/dL), indicating remission of DPLN. 
  While waiting for the next (10th) cyclophosphamide pulse 
therapy, the patient suffered two episodes of massive epistaxis 
and magnetic resonance imaging (MRI) of the paranasal sinuses 
(PNS) showed both maxillary sinusitis and a 1 cm-sized, strong-
ly enhanced lesion in the left sphenoid sinus with focal bony 
defect in the posterolateral aspect of left sphenoid sinus, sug-
gesting aneurysm of the left cavernous ICA.
  The patient was transferred to the interventional neuroradi-
ology unit, where transfemoral cerebral angiography revealed 
one aneurysm in the cavernous segment of the left carotid ar-
tery (Fig. 1A). A graft stent was deployed in the cavernous ICA 
for parent vessel reconstruction, and there was no filling of con-
trast media into the aneurysm at delayed angiography (Fig. 1B). 
Endosinus sphenoidectomy was performed to remove the sus-
pected infection source and to identify the pathogen. Histologi-
cal examination of the sinus mucosa biopsy specimen revealed 
fungal hyphae that were morphologically consistent with As-
pergillus, although the culture study for sinus secretion and re-
peated serum Aspergillus galactomannan antigen assay were 
negative. The patient underwent PNS MRI every two months 
while receiving voriconazole therapy. Since she was still on re-
mission of DPLN with a minimal maintenance dose of steroid 
(daily 5 mg) and in the absence of any evidence of infection such 
as paranasal sinusitis and cerebral mycotic aneurysms on fol-
low up MRI images, voriconazole was stopped seven months 
later.
  Three months after stopping anti-fungal therapy, one small 
aneurysm was suspected at the right middle cerebral artery bi-
furcation on routine follow up MRI images. Transfemoral cere-
bral angiography revealed two aneurysms: one at the right mid-
dle cerebral artery bifurcation, and one at the anterior choroidal 
artery that was not seen on MRI (Fig. 2A). Aneurismal neck clip-
ping of the affected artery was done by a neurosurgeon (Fig. 2B).
  Chest CT and brain MRI images were performed regularly 
afterwards and up to one-year follow-up there was no evidence 
of further infections such as cerebral aneurysms, sinusitis and 
pulmonary nodules.  
DISCUSSION
We report here the first case of aspergillus-related cerebral an-
A B
Fig. 1. (A) Aneurysm involving the cavernous segment of the left carotid artery in transfemoral cerebral angiography (black arrow). (B) Cerebral angiography after deploying 
graft stent in cavernous internal carotid artery for parent vessel reconstruction.Kim YC, et al.  •  Successfully Treated Fungal Infection in Lupus Nephritis
http://jkms.org   319 http://dx.doi.org/10.3346/jkms.2012.27.3.317
eurysm in a lupus patient. Maria et al. (9) first reported 23 cases 
of invasive aspergillosis in SLE, but there was no CNS infection. 
CNS aspergillosis in SLE patients is extremely rare. Uppin et al. 
(10) reported two cases of CNS aspergillosis, in the form of arte-
ritis and thrombosis with bland infarct. One patients had dis-
seminated aspergillosis in the lungs, kidneys and brain, while 
the other was immunocompetent and had sphenoidal sinusitis, 
as in our case. Both patients were diagnosed at autopsy, despite 
extensive imaging and laboratory studies. Lammens et al. (11) 
reported an immunocompromised lupus patient with persis-
tent neutrophilic meningitis which was found at autopsy to be 
due to aspergillosis. Sugawara et al. (12) reported a DPLN pa-
tient with multiple brain abscess who was treated successfully 
by craniectomy and intraventricular antifungal agents. 
  While vascular invasion by Aspergillus species is common, 
true mycotic aneurysm formation due to Aspergillus species is 
rare (13). Mycotic cerebral aneurysm results from direct inva-
sion of the vessel wall, either from the luminal or adventitial side 
of the vessel. Endovascular infection leads to initiation of infec-
tion from the luminal surface whereas infection from the adven-
titial aspect usually occurs in the context of an infectious pro-
cess surrounding the vessel such as in meningitis. Progressive 
invasion of the vascular wall leads to a loss of a vascular integri-
ty and aneurysm formation (14). In the current case, mycotic 
ICA aneurysm was attributed to direct invasion of the sphenoi-
dal fungal sinusitis. It could be diagnosed as CNS aspergillosis 
since proven invasive aspergillosis at a contiguous site such as 
sinuses or orbit is direct evidence to implicate Aspergillus spe-
cies (15). 
  Most infection-associated aneurysms are caused by bacterial 
pathogens, usually secondary to endocarditis. Fungal aneu-
rysms, especially involving carotid artery, are extremely rare. In 
2007, Hot et al. (15) reported a total of 12 cases worldwide of fun-
gal ICA aneurysms since 1968. There were 8 cases with asper-
gillosis but no SLE patients. However, with the prolonged sur-
vival of severely immunocompromised patients, the incidence 
of fungal arterial infections is expected to increase, making the 
recognition of this devastating complication extremely impor-
tant. Fungal aneurysms pose challenges for diagnosis and man-
agement because they are rare, unpredictable, and often occur 
in a clinical context that is neither specific nor alarming. 
  Amphotericin B was the standard therapy for invasive asper-
gillosis until Herbrecht et al. (16) showed that voriconazole had 
a better response and improved survival with fewer severe side 
effects. Voriconazole also showed encouraging efficacy in CNS 
aspergillosis (17). This is because voriconazole (349 Da.) dis-
plays more enhanced penetration against the blood-brain bar-
rier (Ed- the acronym BBB is unnecessary as it is not used any-
where else in the paper) than other relatively large antifungal 
agents such as amphotericin B (700 Da.).
  In The Infectious Disease Society of America (IDSA) 2008 
guidelines for CNS aspergillosis, voriconazole is the primary 
recommendation for systemic antifungal therapy. Surgical re-
section of lesions maybe the definitive treatment and may pre-
vent serious neurological sequelae. Treatment of contiguous 
infection of the PNS is necessary.  
  Open surgical procedure, such as ligation of the affected ar-
tery, has generally been accepted as the technique of choice for 
carotid aneurysms (18). However, recent reports have advocat-
ed the use of minimally invasive endovascular therapy (coil em-
bolization or graft stent insertion) as an alternative approach 
for such aneurysms (19). The pitfall of endovascular therapy is 
that the coil of the graft could be a potential nidus for persistent 
infection (19). In our case, after graft stent insertion, two mycotic 
aneurysms recurred in distal sites of cerebral arteries, suggesting 
that the graft stent might have been the infection source. After 
surgical ligation for the aneurysms, subsequent infection had 
not occurred at one-year follow-up.
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Fig. 2. (A) Aneurysm at right middle cerebral artery bifurcation (black arrow) and tiny aneurysm at the origin of right anterior choroidal artery (white arrow). (B) Cerebral angiog-
raphy after aneurismal clipping.Kim YC, et al.  •  Successfully Treated Fungal Infection in Lupus Nephritis
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